Grants and Contributions:
Title:
IRAP - Technical feasibility study for the production of a pig vaccine
Agreement Number:
913541
Agreement Value:
$72,800.00
Agreement Date:
Jul 19, 2018 - Jan 31, 2020
Description:
Prevtec Microbia is developing new alternative antibiotic technologies for animal health. This project aims to demonstrate the commercial viability of a new product under development by optimizing its manufacturing process. Activities will include identification of appropriate new methods of analysis as well as methods of expression and purification.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Saint-Hyacinthe, Quebec, CA J2S 0B8
Reference Number:
172-2018-2019-Q3-913541
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
145122081
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 217 days.
Amendment Date
Jun 5, 2019
Recipient's Legal Name:
Prevtec Microbia inc
Federal Riding Name:
Saint-Hyacinthe--Bagot
Federal Riding Number:
24066
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: